FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385808054> ?p ?o ?g. }

• W4385808054 abstract "Abstract Introduction Blood biomarkers have proven useful in Alzheimer’s disease (AD), but little is known about their biological variation (BV), which plays a crucial role in the interpretation of individual patient data. Methods We measured plasma amyloid-β (Aβ42, Aβ40), phosphorylated tau (p-tau181, p-tau217, p-tau231), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) in fasting plasma samples collected weekly over 10 weeks from 20 participants aged 40-60y from the European Biological Variation Study. We determined within- (CV I ) and between-subject (CV G ) BV, analytical variation (CV A ) and reference change values (RCV). Results Biomarkers presented considerable variability in CV I and CV G . Aβ42/Aβ40 had the lowest CV I (∼3%) and p-tau181 the highest (∼16%), while the others ranged from 6-10%. Most RCVs ranged from 20-30% (decrease) and 25-40% (increase). Interpretation We provide BV estimates for AD plasma biomarkers, which can potentially refine their clinical and research interpretation. RCVs might be useful for detecting significant changes between serial measurements when monitoring early disease progression or interventions. Highlights · Plasma Aβ42/Aβ40 presents the lowest between- and within-subject biological variation, but also changes the least in AD patients vs controls. · Plasma p-tau variants significantly vary in their within-subject biological variation, but their substantial fold-changes in AD likely limits the impact of their variability. · Plasma NfL and GFAP demonstrate high between-subject variation, the impact of which will depend on clinical context. · Reference change values can potentially be useful in monitoring early disease progression and the safety/efficacy of interventions on an individual-level. · Serial sampling revealed that unexpectedly high values in heathy invidivuals can be observed, which urges caution when interpreting AD plasma biomarkers based on a single test result. Research in Context Systematic Review We reviewed PubMed for articles and conference abstracts that evaluated the biological variation (BV) of novel Alzheimer’s disease (AD) blood biomarkers. Two previous studies had reported BV estimates for serum glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL). Thus, we aimed to provide the first robust BV estimates for plasma amyloid-β (Aβ) and phosphorylated tau (p-tau) biomarkers, and also for plasma GFAP and NfL in in the same population. Interpretation Plasma biomarkers of key pathological features of AD demonstrate heterogeneity in their within- and between-subject variation. Plasma Aβ42/Aβ40 generally shows lower variability but also changes very modestly in AD patients vs controls. While plasma p-tau variants demonstrate higher variability, its clinical impact is likely limited due to large fold-increases in AD. Plasma NfL and GFAP had the largest between-subject variability, which may impact upon their application in certain contexts. Most research on blood biomarkers so far has been done using either single measurements or repeated measurements over longer (e.g., yearly) time frames; the weekly serial sampling in our study revealed that unexpected outlier values may occur, urging caution in clinical and research interpretation. Future directions Future studies should evaluate the potential clinical impact of the application of BV knowledge upon clinical and research interpretation of AD plasma biomarkers, especially in disease monitoring and in the evaluation of safety and efficacy of novel therapeutic interventions." @default.
• W4385808054 created "2023-08-15" @default.
• W4385808054 creator A5012821364 @default.
• W4385808054 creator A5017574801 @default.
• W4385808054 creator A5019120747 @default.
• W4385808054 creator A5025313057 @default.
• W4385808054 creator A5025681025 @default.
• W4385808054 creator A5028922730 @default.
• W4385808054 creator A5029627319 @default.
• W4385808054 creator A5044108470 @default.
• W4385808054 creator A5044620917 @default.
• W4385808054 creator A5045793010 @default.
• W4385808054 creator A5048432926 @default.
• W4385808054 creator A5049256903 @default.
• W4385808054 creator A5050549744 @default.
• W4385808054 creator A5053530106 @default.
• W4385808054 creator A5055712234 @default.
• W4385808054 creator A5061996148 @default.
• W4385808054 creator A5065389119 @default.
• W4385808054 creator A5066422345 @default.
• W4385808054 creator A5089775204 @default.
• W4385808054 date "2023-08-13" @default.
• W4385808054 modified "2023-10-18" @default.
• W4385808054 title "Biological variation estimates of Alzheimer’s disease plasma biomarkers in healthy individuals" @default.
• W4385808054 cites W1985103439 @default.
• W4385808054 cites W1995389783 @default.
• W4385808054 cites W2000730414 @default.
• W4385808054 cites W2117872000 @default.
• W4385808054 cites W2160935383 @default.
• W4385808054 cites W2167384463 @default.
• W4385808054 cites W2309609927 @default.
• W4385808054 cites W2324336557 @default.
• W4385808054 cites W2384939669 @default.
• W4385808054 cites W2592393182 @default.
• W4385808054 cites W2607318287 @default.
• W4385808054 cites W2738183117 @default.
• W4385808054 cites W2775695442 @default.
• W4385808054 cites W2785757836 @default.
• W4385808054 cites W2798054687 @default.
• W4385808054 cites W2810859406 @default.
• W4385808054 cites W2884801548 @default.
• W4385808054 cites W2885947280 @default.
• W4385808054 cites W2934239961 @default.
• W4385808054 cites W2938221890 @default.
• W4385808054 cites W2966365568 @default.
• W4385808054 cites W2972337999 @default.
• W4385808054 cites W3016011017 @default.
• W4385808054 cites W3016041195 @default.
• W4385808054 cites W3017011217 @default.
• W4385808054 cites W3018431352 @default.
• W4385808054 cites W3041680081 @default.
• W4385808054 cites W3045997188 @default.
• W4385808054 cites W3105290805 @default.
• W4385808054 cites W3106414617 @default.
• W4385808054 cites W3118616512 @default.
• W4385808054 cites W3126449714 @default.
• W4385808054 cites W3131174931 @default.
• W4385808054 cites W3139516972 @default.
• W4385808054 cites W3148505026 @default.
• W4385808054 cites W3164390524 @default.
• W4385808054 cites W3165813453 @default.
• W4385808054 cites W3167068736 @default.
• W4385808054 cites W3170010058 @default.
• W4385808054 cites W3182927843 @default.
• W4385808054 cites W3188383479 @default.
• W4385808054 cites W3199026337 @default.
• W4385808054 cites W3202844549 @default.
• W4385808054 cites W3206837711 @default.
• W4385808054 cites W3210403169 @default.
• W4385808054 cites W3214993261 @default.
• W4385808054 cites W4210357094 @default.
• W4385808054 cites W4280490458 @default.
• W4385808054 cites W4281558685 @default.
• W4385808054 cites W4282913972 @default.
• W4385808054 cites W4283794106 @default.
• W4385808054 cites W4288987676 @default.
• W4385808054 cites W4291184225 @default.
• W4385808054 cites W4292865371 @default.
• W4385808054 cites W4295107480 @default.
• W4385808054 cites W4295693891 @default.
• W4385808054 cites W4297036157 @default.
• W4385808054 cites W4298008358 @default.
• W4385808054 cites W4304893067 @default.
• W4385808054 cites W4306663551 @default.
• W4385808054 cites W4308890634 @default.
• W4385808054 cites W4310461604 @default.
• W4385808054 cites W4310603866 @default.
• W4385808054 cites W4322757582 @default.
• W4385808054 cites W4323294633 @default.
• W4385808054 cites W4361279579 @default.
• W4385808054 cites W4367321693 @default.
• W4385808054 cites W4368342606 @default.
• W4385808054 cites W4377029875 @default.
• W4385808054 cites W4383988705 @default.
• W4385808054 cites W4385660931 @default.
• W4385808054 cites W4386324919 @default.
• W4385808054 doi "https://doi.org/10.1101/2023.08.09.23293841" @default.
• W4385808054 hasPublicationYear "2023" @default.
• W4385808054 type Work @default.
• W4385808054 citedByCount "1" @default.

• next